ClinVar Miner

Submissions for variant NM_001360016.2(G6PD):c.859G>A (p.Glu287Lys)

dbSNP: rs387906471
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics RCV001257425 SCV001429642 uncertain significance Anemia, nonspherocytic hemolytic, due to G6PD deficiency 2020-07-02 criteria provided, single submitter clinical testing A heterozygous missense variation in exon 9 of the G6PD gene that results in the amino acid substitution of Lysine for Glutamic acid at codon 317 was detected. The observed variant has previously been reported in patients affected with G6PD deficiency (Sukumar et al. 2004, Ahluwalia et al. 1992) and lies in the glucose-6-phosphate dehydrogenase, C-terminal domain of the G6PD protein. This variant is a prevalent G6PD variant in the South Asian population, typically associated with partial reduction of enzyme activity. The variant c.949G>A (p.Glu317Lys) has a minor allele frequency of 0.2% and 0.1% in the 1000 genomes and gnomAD databases respectively. The in silico prediction of the variant are possibly damaging by PolyPhen-2 (HumDiv) and damaging by LRT. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as a variant of uncertain significance.
Invitae RCV001257425 SCV004408194 uncertain significance Anemia, nonspherocytic hemolytic, due to G6PD deficiency 2023-02-05 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 287 of the G6PD protein (p.Glu287Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with G6PD-related conditions. ClinVar contains an entry for this variant (Variation ID: 431774). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.